Denali Therapeutics
-$2.37 (-3.17%) As of 5:05 PM UTC today
Why Robinhood?
You can buy or sell DNLI and other stocks, options, and ETFs commission-free!
About DNLI
Denali Therapeutics Inc. Common Stock, also called Denali Therapeutics, is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases.
CEO
Ryan J. Watts
Employees
291
Headquarters
San Francisco, California
Founded
2013
DNLI Key Statistics
Market Cap
8.78B
Price-Earnings Ratio
326.54
Dividend Yield
—
Average Volume
648.47K
High Today
$74.97
Low Today
$72.11
Open Price
$73.80
Volume
373.52K
52 Week High
$93.94
52 Week Low
$22.36
Analyst Ratings
75%
of 12 ratings
Buy
75%
Hold
25%
Sell
0%
DNLI Earnings
-$0.58
$0.25
$1.08
$1.91
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 6, Pre-Market